EP PerMed Logo

EP PerMed Newsletter 23 | 04 November 2026

Dear subscribers,

as we approach the end of 2026, we are pleased to share exciting developments and new opportunities for the personalised medicine community. A key highlight is the announcement of our 4th Joint Transnational Call 2027, focusing on innovative cell and gene therapies. We also celebrate the selection of six projects under our Twinning Call 2026, supporting the implementation of personalised medicine across Europe.

In this edition, we also share insights from our recent visit to South Africa, a new EP PerMed publication on implementing personalised medicine in healthcare, and further funding opportunities and developments relevant to our community. We hope you enjoy reading and invite you to explore the latest news and upcoming events!

The EP PerMed Consortium

 

EP PerMed News

04 November 2026

image

Call Announcement: EP PerMed JTC2027

EP PerMed is launching the Joint Transnational Call 2027 for Cell and Gene Therapy for Personalised Medicine (CGT4PM2027). The call aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine. Deadline for pre-proposal submission is 20 January 2027 (14:00, CET). A call information day will be organised on 03 December 2026.

Read more

02 November 2026

image

EP PerMed Strengthens International Collaboration Through In-situ Visit to South Africa

From 19 to 23 October 2026, EP PerMed representatives visited Cape Town, South Africa, to explore the country’s growing personalised medicine ecosystem and exchange experiences with local researchers, innovators and funding organisations. Hosted by the South African Medical Research Council (SAMRC), the visit coincided with celebrations marking ten years of precision medicine initiatives in South Africa.

Read more

02 November 2027

image

New EP PerMed Publication Highlights Five Priorities for Implementing Personalised Medicine in Healthcare

How can personalised medicine move from scientific innovation into routine clinical practice? A new publication by EP PerMed representatives in the European Medical Specialist Review identifies five key areas for action and highlights the importance of multistakeholder collaboration to advance implementation across European healthcare systems.

Read more

16 October 2026

image

Announcement of Results - EP PerMed Twinning Call 2026

Six high-quality projects have been selected for funding under the EP PerMed Twinning Call 2026, an initiative designed to accelerate the implementation of personalised medicine approaches across Europe through the transfer of knowledge, expertise, and proven practices between healthcare organisations.

Read more

Other PM-related News

04 November 2026

image

Open Research Europe Relaunches: Open Access Publishing for EP PerMed Projects

Researchers and innovators funded by EP PerMed can publish free of charge on Open Research Europe (ORE). Relaunched on 2 November 2026, the platform offers open access publishing with transparent peer review and a wide choice of article formats.

Read more

29 October 2026

image

Integrating Genome Medicine into Healthcare in Germany: The genomDE Model Project

As part of the ICPerMed Strategic Working Group on Internationalisation, a webinar titled ‘Integrating Genome Medicine into Healthcare in Germany: The genomDE Model Project‘ was organised on 29 October 2026. The webinar recording is now available.

Read more

29 October 2026

image

White Paper Explores Healthcare-Specific Considerations for Artificial Intelligence

The International Organization for Standardization (ISO) has published a new white paper examining how the specific characteristics of healthcare influence the development, evaluation and implementation of artificial intelligence (AI). The report provides valuable insights for researchers and innovators working on AI-driven solutions in personalised medicine.

Read more

28 October 2026

image

New Horizon Europe Call: Personalised Approaches to Reduce Adverse Drug Reactions

A new Horizon Europe call provides €38 million to support research into personalised approaches to improve medication safety and reduce adverse drug reactions in patients taking multiple medications. The call focuses on pharmacogenomics, biomarkers and digital technologies to enable safer, more effective and personalised treatment strategies.

Read more

21 October 2026

image

IHI Publishes Draft Topics for Calls 14 and 15, with New Opportunities for Personalised Medicine

The Innovative Health Initiative (IHI) has published six draft topics for its upcoming Calls 14 and 15, expected to launch in early 2027. Several topics are particularly relevant to personalised medicine, addressing predictive health technologies, patient-centred care, advanced therapies and clinical evidence generation.

Read more

See all news

Events

16 November 2026 - TEHDAS2 Final Conference

16 November 2026 - PRECISEU 4th Personalised Medicine School

24 - 25 November 2026 - HNN3.0 | Brokerage Event on Horizon Europe Cluster 1 2027 Calls

26 November 2026 - Horizon Europe Info Days - Cluster 1

01 December 2026 - Open Research Europe (ORE) Launch Event

02 December 2026 - European Life Sciences: driving an Innovative Economy

03 December 2026 - EP PerMed JTC2027 Information Day

04 December 2026 - 1+ Million Genomes Initiative – High-level Event

18 - 21 January 2027 - PRISM Networking Event: Digital Twins for Personalised Radiotherapy through Integrated Simulation and Modelling

27 - 29 April 2027 - Joint EP PerMed & ICPerMed Conference in Berlin

See all events

EUROPEAN PARTNERSHIP

EP PerMed has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101137129.

Imprint

EP PerMed is coordinated by:
DLR Projektträger
Health | Innovations for Disease Control
Heinrich-Konen-Straße 1
53227 Bonn, Germany

phone +49 228 3821-1144
e-mail: eppermed@dlr.de

www.eppermed.eu | LinkedIn | www.DLR-PT.de

For information about data protection, please see our Privacy Policy

You receive this email because you have registered for the EP PerMed Newsletter. If you want to unsubscribe please click here.